Establishing a cryopreservation protocol for patient‐derived xenografts of prostate cancer

[1]  T. Schlomm,et al.  Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer , 2018, Scientific Reports.

[2]  Shivakumar Keerthikumar,et al.  Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy. , 2018, European urology.

[3]  Jianyi(Jay) Zhang,et al.  Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice , 2018, Cardiovascular research.

[4]  Yuzhuo Wang,et al.  Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient‐derived xenograft (PDX) models , 2018, The Prostate.

[5]  G. Risbridger,et al.  Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models. , 2018, Cold Spring Harbor perspectives in medicine.

[6]  G. Risbridger,et al.  Towards best practice in establishing patient-derived xenografts , 2017 .

[7]  Min-Jung Kim,et al.  Long-term culture-induced phenotypic difference and efficient cryopreservation of small intestinal organoids by treatment timing of Rho kinase inhibitor , 2017, World journal of gastroenterology.

[8]  A. Mantalaris,et al.  Human embryonic and induced pluripotent stem cells maintain phenotype but alter their metabolism after exposure to ROCK inhibitor , 2017, Scientific Reports.

[9]  P. Nelson,et al.  LuCaP Prostate Cancer Patient‐Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics , 2017, The Prostate.

[10]  Hans Clevers,et al.  Interrogating open issues in cancer precision medicine with patient-derived xenografts , 2017, Nature Reviews Cancer.

[11]  Anthony T Papenfuss,et al.  A community-based model of rapid autopsy in end-stage cancer patients , 2016, Nature Biotechnology.

[12]  Matthew J. Wakefield,et al.  Xenomapper: Mapping reads in a mixed species context , 2016, J. Open Source Softw..

[13]  Joshua M. Korn,et al.  High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response , 2015, Nature Medicine.

[14]  M. Frydenberg,et al.  Establishment of primary patient‐derived xenografts of palliative TURP specimens to study castrate‐resistant prostate cancer , 2015, The Prostate.

[15]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[16]  Jeffrey H. Chuang,et al.  The JAX patient-derived xenograft program: A unique resource to advance genome-guided cancer medicine and therapeutic agent testing. , 2014 .

[17]  A. Pellicer,et al.  Improving ovarian tissue cryopreservation for oncologic patients: slow freezing versus vitrification, effect of different procedures and devices. , 2014, Fertility and sterility.

[18]  F. Tanihara,et al.  Generation of Live Piglets for the First Time Using Sperm Retrieved from Immature Testicular Tissue Cryopreserved and Grafted into Nude Mice , 2013, PloS one.

[19]  M. Frydenberg,et al.  A preclinical xenograft model of prostate cancer using human tumors , 2013, Nature Protocols.

[20]  W. Shi,et al.  The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote , 2013, Nucleic acids research.

[21]  A. van Langendonckt,et al.  Vitrification preserves proliferation capacity in human spermatogonia. , 2013, Human reproduction.

[22]  M. Robinson,et al.  A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.

[23]  A. Rizzino,et al.  ROCK inhibition enhances the recovery and growth of cryopreserved human embryonic stem cells and human induced pluripotent stem cells , 2009, Molecular reproduction and development.

[24]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[25]  D. Baker,et al.  Novel cryopreservation method for dissociated human embryonic stem cells in the presence of a ROCK inhibitor. , 2008, Human reproduction.

[26]  S. Nishikawa,et al.  A ROCK inhibitor permits survival of dissociated human embryonic stem cells , 2007, Nature Biotechnology.

[27]  J. Isaacs,et al.  The quinoline‐3‐carboxamide anti‐angiogenic agent, tasquinimod, enhances the anti‐prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts , 2007, The Prostate.

[28]  K. Pienta,et al.  Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  S. Schwartz,et al.  CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. , 1996, Cancer research.

[30]  M. Resnick,et al.  Xenografts of primary human prostatic carcinoma. , 1993, Journal of the National Cancer Institute.

[31]  A. McCullough.  ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells , 2013 .

[32]  M. Frydenberg,et al.  Primary culture and propagation of human prostate epithelial cells. , 2013, Methods in molecular biology.